| Name | Title | Contact Details |
|---|
Lancor is a global retained executive search firm serving public and private companies, private equity firms and other investors. We specialize in board level search mandates including CEO, CFO, C suite executives, board director and private equity ope...
If you want to know about elite, we think you should get in touch. Why brag about our expertise in recruitment—both the people and the processes that bring them together? Why wear out our fingertips explaining all about partnership and strategy and technology enablement and consultative approach? Why waste valuable time telling you we love our jobs, when it`s a whole lot more fun to be in on the action? Besides, that would give us the opportunity to start building a relationship (and scope you out too).
FireSeeds is a company that helps organizations grow and scale their business through multiplying leaders. Their services include executive and mid-level recruiting, online leader development through their Wildsparq platform, and consulting to define a...
Originally founded in 1992 as a niche site management organization, D. Anderson & Company emerged as a model for crafting clinical strategies based on investigative site needs. Today as DAC Patient Recruitment Services, an Imperial company, we`ve parlayed that experience into our current, site-focused business model. Effective March 29, 2011, DAC was acquired by Imperial—a privately owned clinical research support organization with offices in Michigan, New Jersey and the United Kingdom. Since its origins in 1945, Imperial, has become one of the world`s premier support organizations for clinical trial sponsors and contract research organizations. With unified standards, central management and streamlined client communication, the Imperial Family of Companies includes DAC Patient Recruitment Services, ClinicaLingua Translations Services and Imperial Graphics--three vertically integrated brands offering clients true service synergy. Together, we`re taking patient recruitment for clinical trials to a higher level with unique strategies that yield rapid enrollment, risk reduction and return on investment. Our unique strategies have boosted enrollment by 100 percent and reduced attrition by 48 percent on average. We`ve successfully managed recruitment and retention programs representing 100,000 patients at 16,000 sites around the world.